|Other Names||Growth/differentiation factor 9, GDF-9, GDF9|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells.|
|Tissue Location||Expressed in ovarian granulosa cells. Present in oocytes of primary follicles (at protein level)|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Growth factors synthesized by ovarian somatic cellsdirectly affect oocyte growth and function. Growth differentiationfactor-9 (GDF9) is expressed in oocytes and is thought to berequired for ovarian folliculogenesis. GDF9 is a member of thetransforming growth factor-beta superfamily.
Bokobza, S.M., et al. J. Cell. Physiol. 225(2):529-536(2010)Wang, T.T., et al. Fertil. Steril. 94(6):2490-2492(2010)Shi, F.T., et al. J. Clin. Endocrinol. Metab. 95 (10), E172-E180 (2010) :Sproul, K., et al. BJOG 117(6):756-760(2010)Davila, S., et al. Genes Immun. 11(3):232-238(2010)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.